Regulation of the DNA damage response to DSBs by post-translational modifications

Current Genomics

Volumn 11, Issue 3, 2010, Pages 184-198

  Oberle, C ^a   Blattner, C ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Cell cycle arrest; DNA double strand breaks; Homologous recombination; Non homologous endjoining; Post translational modifications

Indexed keywords

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; DNA DAMAGE; DNA MODIFICATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; RNA TRANSLATION; SIGNAL TRANSDUCTION;

EID: 77952526095     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920210791110979     Document Type: Article

References (184)

1. Hoeijmakers, J.H. DNA repair mechanisms. Maturitas, 2001, 38, 17-22.
2. Khanna, K.K.; Jackson, S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet., 2001, 27, 247-254.
3. Keeney, S.; Neale, M.J. Initiation of meiotic recombination by formation of DNA double-strand breaks: mechanism and regulation. Biochem. Soc. Trans., 2006, 34, 523-525.
4. Jolly, C.J.; Cook, A.J.; Manis, J.P. Fixing DNA breaks during class switch recombination. J. Exp. Med., 2008, 205, 509-513.
5. Fortini, P.; Dogliotti, E. Base damage and single-strand break repair: mechanisms and functional significance of short- and longpatch repair subpathways. DNA Repair (Amst), 2007, 6, 398-409.
6. Nouspikel, T. DNA repair in mammalian cells: Nucleotide excision repair: variations on versatility. Cell Mol. Life Sci., 2009, 66, 994-1009.
7. Hsieh, P.; Yamane, K. DNA mismatch repair: molecular mechanism, cancer, and ageing. Mech. Ageing Dev., 2008, 129, 391-407.
8. Salazar, C.; Hofer, T. Multisite protein phosphorylation-from molecular mechanisms to kinetic models. FEBS J., 2009, 276, 3177-3198.
9. Shi, Y. Serine/threonine phosphatases: mechanism through structure. Cell, 2009, 139, 468-484.
10. Kouzarides, T. Acetylation: a regulatory modification to rival phosphorylation? EMBO J., 2000, 19, 1176-1179.
11. Paik, W.K.; Paik, D.C.; Kim, S. Historical review: the field of protein methylation. Trends Biochem. Sci., 2007, 32, 146-152.
12. Gu, W.; Roeder, R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 1997, 90, 595-606.
13. Chuikov, S.; Kurash, J.K.; Wilson, J.R.; Xiao, B.; Justin, N.; Ivanov, G.S.; McKinney, K.; Tempst, P.; Prives, C.; Gamblin, S.J.; Barlev, N.A.; Reinberg, D. Regulation of p53 activity through lysine methylation. Nature, 2004, 432, 353-360.
14. Hershko, A. Ubiquitin-mediated protein degradation. J. Biol. Chem., 1988, 263, 15237-15240.
15. Kerscher, O.; Felberbaum, R.; Hochstrasser, M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol., 2006, 22, 159-180.
16. Hochstrasser, M. Origin and function of ubiquitin-like proteins. Nature, 2009, 458, 422-429.
17. Ande, S.R.; Chen, J.; Maddika, S. The ubiquitin pathway: An emerging drug target in cancer therapy. Eur. J. Pharmacol., 2009, 625(1-3), 199-205
18. Haglund, K.; Stenmark, H. Working out coupled monoubiquitination. Nat. Cell Biol., 2006, 8, 1218-1219.
19. Ikeda, F.; Dikic, I. Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep., 2008, 9, 536-542.
20. Herrmann, J.; Lerman, L.O.; Lerman, A. Ubiquitin and ubiquitin-like proteins in protein regulation. Circ. Res., 2007, 100, 1276-1291.
21. Saeki, Y.; Kudo, T.; Sone, T.; Kikuchi, Y.; Yokosawa, H.; Toh-e A; Tanaka, K. Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome. EMBO J., 2009, 28, 359-371.
22. Wang, B.; Elledge, S.J. Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc. Natl. Acad. Sci. USA, 2007, 104, 20759-20763.
23. Chastagner, P.; Israel, A.; Brou, C. Itch/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains. EMBO Rep., 2006, 7, 1147-1153.
24. Kim, H.T.; Kim, K.P.; Lledias, F.; Kisselev, A.F.; Scaglione, K.M.; Skowyra, D.; Gygi, S.P.; Goldberg, A.L. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J. Biol. Chem., 2007, 282, 17375-17386.
25. Wickliffe, K.; Williamson, A.; Jin, L.; Rape, M. The multiple layers of ubiquitin-dependent cell cycle control. Chem. Rev., 2009, 109, 1537-1548.
26. Hay, R.T. SUMO: a history of modification. Mol. Cell, 2005, 18, 1-12.
27. Guo, B.; Yang, S.H.; Witty, J.; Sharrocks, A.D. Signalling pathways and the regulation of SUMO modification. Biochem. Soc. Trans., 2007, 35, 1414-1418.
28. Reverter, D.; Lima, C.D. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature, 2005, 435, 687-692.
29. Bernier-Villamor, V.; Sampson, D.A.; Matunis, M.J.; Lima, C.D. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and Ran-GAP1. Cell, 2002, 108, 345-356.
30. Rodriguez, M.S.; Dargemont, C.; Hay, R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem., 2001, 276, 12654-12659.
31. Pedrioli, P.G.; Raught, B.; Zhang, X.D.; Rogers, R.; Aitchison, J.; Matunis, M.; Aebersold, R. Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software. Nat. Methods, 2006, 3, 533-539.
32. Cooper, H.J.; Tatham, M.H.; Jaffray, E.; Heath, J.K.; Lam, T.T.; Marshall, A.G.; Hay, R.T. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 auto-SUMOylation reaction. Anal. Chem., 2005, 77, 6310-6319.
33. Hietakangas, V.; Anckar, J.; Blomster, H.A.; Fujimoto, M.; Palvimo, J.J.; Nakai, A.; Sistonen, L. PDSM, a motif for phos-phorylation-dependent SUMO modification. Proc. Natl. Acad. Sci. USA, 2006, 103, 45-50.
34. Yang, S.H.; Galanis, A.; Witty, J.; Sharrocks, A.D. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J., 2006, 25, 5083-5093.
35. Lin, J.Y.; Ohshima, T.; Shimotohno, K. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53. FEBS Lett., 2004, 573, 15-18.
36. Melchior, F. SUMO--nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol., 2000, 16, 591-626.
37. Guo, D.; Li, M.; Zhang, Y.; Yang, P.; Eckenrode, S.; Hopkins, D.; Zheng, W.; Purohit, S.; Podolsky, R.H.; Muir, A.; Wang, J.; Dong, Z.; Brusko, T.; Atkinson, M.; Pozzilli, P.; Zeidler, A.; Raffel, L.J.; Jacob, C.O.; Park, Y.; Serrano-Rios, M.; Larrad, M.T.; Zhang, Z.; Garchon, H.J.; Bach, J.F.; Rotter, J.I.; She, J.X.; Wang, C.Y. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat. Genet., 2004, 36, 837-841.
38. Bohren, K.M.; Nadkarni, V.; Song, J.H.; Gabbay, K.H.; Owerbach, D. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem., 2004, 279, 27233-27238.
39. Owerbach, D.; McKay, E.M.; Yeh, E.T.; Gabbay, K.H.; Bohren, K.M. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem. Biophys. Res. Commun., 2005, 337, 517-520.
40. Yang, M.; Hsu, C.T.; Ting, C.Y.; Liu, L.F.; Hwang, J. Assembly of a polymeric chain of SUMO1 on human topoisomerase I in vitro. J. Biol. Chem., 2006, 281, 8264-8274.
41. Xirodimas, D.P. Novel substrates and functions for the ubiquitin-like molecule NEDD8. Biochem. Soc. Trans., 2008, 36, 802-806.
42. Chamovitz, D.A. Revisiting the COP9 signalosome as a transcriptional regulator. EMBO Rep., 2009, 10, 352-358.
43. Lee, J.H.; Paull, T.T. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene, 2007, 26, 7741-7748.
44. Goodarzi, A.A.; Jonnalagadda, J.C.; Douglas, P.; Young, D.; Ye, R.; Moorhead, G.B.; Lees-Miller, S.P.; Khanna, K.K. Autophos-phorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J., 2004, 23, 4451-4461.
45. Ali, A.; Zhang, J.; Bao, S.; Liu, I.; Otterness, D.; Dean, N.M.; Abraham, R.T.; Wang, X.F. Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. Genes Dev., 2004, 18, 249-254.
46. Bakkenist, C.J.; Kastan, M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature, 2003, 421, 499-506.
47. Kozlov, S.V.; Graham, M.E.; Peng, C.; Chen, P.; Robinson, P.J.; Lavin, M.F. Involvement of novel autophosphorylation sites in ATM activation. EMBO J., 2006, 25, 3504-3514.
48. Dupre, A.; Boyer-Chatenet, L.; Gautier, J. Two-step activation of ATM by DNA and the Mre11-Rad50-Nbs1 complex. Nat. Struct. Mol. Biol., 2006, 13, 451-457.
49. Pellegrini, M.; Celeste, A.; Difilippantonio, S.; Guo, R.; Wang, W.; Feigenbaum, L.; Nussenzweig, A. Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo. Nature, 2006, 443, 222-225.
50. Daniel, J.A.; Pellegrini, M.; Lee, J.H.; Paull, T.T.; Feigenbaum, L.; Nussenzweig, A. Multiple autophosphorylation sites are dispensable for murine ATM activation in vivo. J. Cell Biol., 2008, 183, 777-783.
51. Sun, Y.; Xu, Y.; Roy, K.; Price, B.D. DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity. Mol. Cell Biol., 2007, 27, 8502-8509.
52. Guo, J.Y.; Yamada, A.; Kajino, T.; Wu, J.Q.; Tang, W.; Freel, C.D.; Feng, J.; Chau, B.N.; Wang, M.Z.; Margolis, S.S.; Yoo, H.Y.; Wang, X.F.; Dunphy, W.G.; Irusta, P.M.; Hardwick, J.M.; Kornbluth, S. Aven-dependent activation of ATM following DNA damage. Curr. Biol., 2008, 18, 933-942.
53. Gottlieb, T.M.; Jackson, S.P. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell, 1993, 72, 131-142.
54. Walker, J.R.; Corpina, R.A.; Goldberg, J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature, 2001, 412, 607-614.
55. Sheppard, H.M.; Liu, X. Phosphorylation by DNAPK inhibits the DNA-binding function of p53/T antigen complex in vitro. Anticancer Res., 1999, 19, 2079-2083.
56. Stiff, T.; O'Driscoll, M.; Rief, N.; Iwabuchi, K.; Lobrich, M.; Jeggo, P.A. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res., 2004, 64, 2390-2396.
57. Goodarzi, A.A.; Yu, Y.; Riballo, E.; Douglas, P.; Walker, S.A.; Ye, R.; Harer, C.; Marchetti, C.; Morrice, N.; Jeggo, P.A.; Lees-Miller, S.P. DNA-PK autophosphorylation facilitates Artemis endonuclease activity. EMBO J., 2006, 25, 3880-3889.
58. Yu, Y.; Mahaney, B.L.; Yano, K.; Ye, R.; Fang, S.; Douglas, P.; Chen, D.J.; Lees-Miller, S.P. DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for repair of DNA double strand breaks. DNA Repair (Amst), 2008, 7, 1680-1692.
59. Chan, D.W.; Chen, B.P.; Prithivirajsingh, S.; Kurimasa, A.; Story, M.D.; Qin, J.; Chen, D.J. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev., 2002, 16, 2333-2338.
60. Maas, N.L.; Miller, K.M.; DeFazio, L.G.; Toczyski, D.P. Cell cycle and checkpoint regulation of histone H3 K56 acetylation by Hst3 and Hst4. Mol. Cell, 2006, 23, 109-119.
61. Qin, S.; Parthun, M.R. Recruitment of the type B histone acetyl-transferase Hat1p to chromatin is linked to DNA double-strand breaks. Mol. Cell Biol., 2006, 26, 3649-3658.
62. Botuyan, M.V.; Lee, J.; Ward, I.M.; Kim, J.E.; Thompson, J.R.; Chen, J.; Mer, G. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell, 2006, 127, 1361-1373.
63. Downs, J.A.; Lowndes, N.F.; Jackson, S.P. A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature, 2000, 408, 1001-1004.
64. Rogakou, E.P.; Pilch, D.R.; Orr, A.H.; Ivanova, V.S.; Bonner, W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem., 1998, 273, 5858-5868.
65. Wang, H.; Zhai, L.; Xu, J.; Joo, H.Y.; Jackson, S.; Erdjument-Bromage, H.; Tempst, P.; Xiong, Y.; Zhang, Y. Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage. Mol. Cell, 2006, 22, 383-394.
66. Huyen, Y.; Zgheib, O.; Ditullio, R.A., Jr.; Gorgoulis, V.G.; Zacharatos, P.; Petty, T.J.; Sheston, E.A.; Mellert, H.S.; Stavridi, E.S.; Halazonetis, T.D. Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature, 2004, 432, 406-411.
67. Paull, T.T.; Rogakou, E.P.; Yamazaki, V.; Kirchgessner, C.U.; Gellert, M.; Bonner, W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol., 2000, 10, 886-895.
68. Lukas, C.; Melander, F.; Stucki, M.; Falck, J.; Bekker-Jensen, S.; Goldberg, M.; Lerenthal, Y.; Jackson, S.P.; Bartek, J.; Lukas, J. Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention. EMBO J., 2004, 23, 2674-2683.
69. Stucki, M.; Clapperton, J.A.; Mohammad, D.; Yaffe, M.B.; Smerdon, S.J.; Jackson, S.P. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell, 2005, 123, 1213-1226.
70. Uziel, T.; Lerenthal, Y.; Moyal, L.; Andegeko, Y.; Mittelman, L.; Shiloh, Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J., 2003, 22, 5612-5621.
71. Bressan, D.A.; Baxter, B.K.; Petrini, J.H. The Mre11-Rad50-Xrs2 protein complex facilitates homologous recombination-based double-strand break repair in Saccharomyces cerevisiae. Mol. Cell Biol., 1999, 19, 7681-7687.
72. Moreau, S.; Ferguson, J.R.; Symington, L.S. The nuclease activity of Mre11 is required for meiosis but not for mating type switching, end joining, or telomere maintenance. Mol. Cell Biol., 1999, 19, 556-566.
73. Seno, J.D.; Dynlacht, J.R. Intracellular redistribution and modification of proteins of the Mre11/Rad50/Nbs1 DNA repair complex following irradiation and heat-shock. J. Cell Physiol., 2004, 199, 157-170.
74. Paull, T.T.; Gellert, M. The 3' to 5' exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks. Mol. Cell, 1998, 1, 969-979.
75. de Jager, M.; van Noort, J.; van Gent, D.C.; Dekker, C.; Kanaar, R.; Wyman, C. Human Rad50/Mre11 is a flexible complex that can tether DNA ends. Mol. Cell, 2001, 8, 1129-1135.
76. Hopfner, K.P.; Craig, L.; Moncalian, G.; Zinkel, R.A.; Usui, T.; Owen, B.A.; Karcher, A.; Henderson, B.; Bodmer, J.L.; McMurray, C.T.; Carney, J.P.; Petrini, J.H.; Tainer, J.A. The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination andrepair. Nature, 2002, 418, 562-566.
77. Wiltzius, J.J.; Hohl, M.; Fleming, J.C.; Petrini, J.H. The Rad50 hook domain is a critical determinant of Mre11 complex functions. Nat. Struct. Mol. Biol., 2005, 12, 403-407.
78. Helmink, B.A.; Bredemeyer, A.L.; Lee, B.S.; Huang, C.Y.; Sharma, G.G.; Walker, L.M.; Bednarski, J.J.; Lee, W.L.; Pandita, T.K.; Bassing, C.H.; Sleckman, B.P. MRN complex function in the repair of chromosomal Rag-mediated DNA double-strand breaks. J. Exp. Med., 2009, 206, 669-679.
79. Williams, R.S.; Moncalian, G.; Williams, J.S.; Yamada, Y.; Limbo, O.; Shin, D.S.; Groocock, L.M.; Cahill, D.; Hitomi, C.; Guenther, G.; Moiani, D.; Carney, J.P.; Russell, P.; Tainer, J.A. Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair. Cell, 2008, 135, 97-109.
80. Zhu, J.; Petersen, S.; Tessarollo, L.; Nussenzweig, A. Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr. Biol., 2001, 11, 105-109.
81. Xiao, Y.; Weaver, D.T. Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mre11 protein in murine embryonic stem cells. Nucleic Acids Res., 1997, 25, 2985-2991.
82. Antoccia, A.; Kobayashi, J.; Tauchi, H.; Matsuura, S.; Komatsu, K. Nijmegen breakage syndrome and functions of the responsible protein, NBS1. Genome Dyn., 2006, 1, 191-205.
83. Taylor, A.M.; Groom, A.; Byrd, P.J. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair (Amst), 2004, 3, 1219-1225.
84. Lee, J.H.; Paull, T.T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science, 2005, 308, 551-554.
85. Girard, P.M.; Riballo, E.; Begg, A.C.; Waugh, A.; Jeggo, P.A. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest. Oncogene, 2002, 21, 4191-4199.
86. Kitagawa, R.; Bakkenist, C.J.; McKinnon, P.J.; Kastan, M.B. Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev., 2004, 18, 1423-1438.
87. Jazayeri, A.; Balestrini, A.; Garner, E.; Haber, J.E.; Costanzo, V. Mre11-Rad50-Nbs1-dependent processing of DNA breaks generates oligonucleotides that stimulate ATM activity. EMBO J., 2008, 27, 1953-1962.
88. Kim, J.S.; Krasieva, T.B.; Kurumizaka, H.; Chen, D.J.; Taylor, A.M.; Yokomori, K. Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells. J. Cell Biol., 2005, 170, 341-347.
89. Lim, D.S.; Kim, S.T.; Xu, B.; Maser, R.S.; Lin, J.; Petrini, J.H.; Kastan, M.B. ATM phosphorylates p95/nbs1 in an S-phase check-point pathway. Nature, 2000, 404, 613-617.
90. Stewart, G.S.; Wang, B.; Bignell, C.R.; Taylor, A.M.; Elledge, S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature, 2003, 421, 961-966.
91. Durocher, D.; Jackson, S.P. The FHA domain. FEBS Lett., 2002, 513, 58-66.
92. Manke, I.A.; Lowery, D.M.; Nguyen, A.; Yaffe, M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science, 2003, 302, 636-639.
93. Lou, Z.; Minter-Dykhouse, K.; Franco, S.; Gostissa, M.; Rivera, M.A.; Celeste, A.; Manis, J.P.; van Deursen, J.; Nussenzweig, A.; Paull, T.T.; Alt, F.W.; Chen, J. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol. Cell, 2006, 21, 187-200.
94. Lou, Z.; Chen, B.P.; Asaithamby, A.; Minter-Dykhouse, K.; Chen, D.J.; Chen, J. MDC1 regulates DNA-PK autophosphorylation in response to DNA damage. J. Biol. Chem., 2004, 279, 46359-46362.
95. Bekker-Jensen, S.; Lukas, C.; Melander, F.; Bartek, J.; Lukas, J. Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1. J. Cell Biol., 2005, 170, 201-211.
96. Mailand, N.; Bekker-Jensen, S.; Faustrup, H.; Melander, F.; Bartek, J.; Lukas, C.; Lukas, J. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell, 2007, 131, 887-900.
97. Stewart, G.S.; Panier, S.; Townsend, K.; Al Hakim, A.K.; Kolas, N.K.; Miller, E.S.; Nakada, S.; Ylanko, J.; Olivarius, S.; Mendez, M.; Oldreive, C.; Wildenhain, J.; Tagliaferro, A.; Pelletier, L.; Taubenheim, N.; Durandy, A.; Byrd, P.J.; Stankovic, T.; Taylor, A.M.; Durocher, D. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell, 2009, 136, 420-434.
98. Wang, B.; Matsuoka, S.; Ballif, B.A.; Zhang, D.; Smogorzewska, A.; Gygi, S.P.; Elledge, S.J. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science, 2007, 316, 1194-1198.
99. Cantor, S.B.; Bell, D.W.; Ganesan, S.; Kass, E.M.; Drapkin, R.; Grossman, S.; Wahrer, D.C.; Sgroi, D.C.; Lane, W.S.; Haber, D.A.; Livingston, D.M. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell, 2001, 105, 149-160.
100. Yu, X.; Chen, J. DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains. Mol. Cell Biol., 2004, 24, 9478-9486.
101. Dong, Y.; Hakimi, M.A.; Chen, X.; Kumaraswamy, E.; Cooch, N.S.; Godwin, A.K.; Shiekhattar, R. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol. Cell, 2003, 12, 1087-1099.
102. Chen, X.; Arciero, C.A.; Wang, C.; Broccoli, D.; Godwin, A.K. BRCC36 is essential for ionizing radiation-induced BRCA1 phosphorylation and nuclear foci formation. Cancer Res., 2006, 66, 5039-5046.
103. Shao, G.; Lilli, D.R.; Patterson-Fortin, J.; Coleman, K.A.; Morrissey, D.E.; Greenberg, R.A. The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks. Proc. Natl. Acad. Sci. USA, 2009, 106, 3166-3171.
104. Zhuang, J.; Zhang, J.; Willers, H.; Wang, H.; Chung, J.H.; van Gent, D.C.; Hallahan, D.E.; Powell, S.N.; Xia, F. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining. Cancer Res., 2006, 66, 1401-1408.
105. Wei, L.; Lan, L.; Hong, Z.; Yasui, A.; Ishioka, C.; Chiba, N. Rapid recruitment of BRCA1 to DNA double-strand breaks is dependent on its association with Ku80. Mol. Cell Biol., 2008, 28, 7380-7393.
106. Iwabuchi, K.; Bartel, P.L.; Li, B.; Marraccino, R.; Fields, S. Two cellular proteins that bind to wild-type but not mutant p53. Proc. Natl. Acad. Sci. USA, 1994, 91, 6098-6102.
107. Lee, H.; Kwak, H.J.; Cho, I.T.; Park, S.H.; Lee, C.H. S1219 residue of 53BP1 is phosphorylated by ATM kinase upon DNA damage and required for proper execution of DNA damage response. Biochem. Biophys. Res. Commun., 2009, 378, 32-36.
108. Wang, B.; Matsuoka, S.; Carpenter, P.B.; Elledge, S.J. 53BP1, a mediator of the DNA damage checkpoint. Science, 2002, 298, 1435-1438.
109. Mochan, T.A.; Venere, M.; Ditullio, R.A., Jr.; Halazonetis, T.D. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res., 2003, 63, 8586-8591.
110. Takata, M.; Sasaki, M.S.; Sonoda, E.; Morrison, C.; Hashimoto, M.; Utsumi, H.; Yamaguchi-Iwai, Y.; Shinohara, A.; Takeda, S. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J., 1998, 17, 5497-5508.
111. Rothkamm, K.; Kruger, I.; Thompson, L.H.; Lobrich, M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol. Cell Biol., 2003, 23, 5706-5715.
112. Delacote, F.; Han, M.; Stamato, T.D.; Jasin, M.; Lopez, B.S. An xrcc4 defect or Wortmannin stimulates homologous recombination specifically induced by double-strand breaks in mammalian cells. Nucleic Acids Res., 2002, 30, 3454-3463.
113. Frank-Vaillant, M.; Marcand, S. Transient stability of DNA ends allows nonhomologous end joining to precede homologous recombination. Mol. Cell, 2002, 10, 1189-1199.
114. Feldmann, E.; Schmiemann, V.; Goedecke, W.; Reichenberger, S.; Pfeiffer, P. DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining. Nucleic Acids Res., 2000, 28, 2585-2596.
115. Smith, G.C.; Divecha, N.; Lakin, N.D.; Jackson, S.P. DNA-dependent protein kinase and related proteins. Biochem. Soc. Symp., 1999, 64, 91-104.
116. Riballo, E.; Critchlow, S.E.; Teo, S.H.; Doherty, A.J.; Priestley, A.; Broughton, B.; Kysela, B.; Beamish, H.; Plowman, N.; Arlett, C.F.; Lehmann, A.R.; Jackson, S.P.; Jeggo, P.A. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr. Biol., 1999, 9, 699-702.
117. Grawunder, U.; Zimmer, D.; Kulesza, P.; Lieber, M.R. Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V(D)J recombination and DNA double-strand break repair in vivo. J. Biol. Chem., 1998, 273, 24708-24714.
118. Ahnesorg, P.; Smith, P.; Jackson, S.P. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell, 2006, 124, 301-313.
119. Buck, D.; Malivert, L.; de Chasseval, R.; Barraud, A.; Fondaneche, M.C.; Sanal, O.; Plebani, A.; Stephan, J.L.; Hufnagel, M.; le Deist, F.; Fischer, A.; Durandy, A.; de Villartay, J.P.; Revy, P. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell, 2006, 124, 287-299.
120. Rooney, S.; Alt, F.W.; Lombard, D.; Whitlow, S.; Eckersdorff, M.; Fleming, J.; Fugmann, S.; Ferguson, D.O.; Schatz, D.G.; Sekiguchi, J. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J. Exp. Med., 2003, 197, 553-565.
121. Rooney, S.; Sekiguchi, J.; Zhu, C.; Cheng, H.L.; Manis, J.; Whitlow, S.; DeVido, J.; Foy, D.; Chaudhuri, J.; Lombard, D.; Alt, F.W. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol. Cell, 2002, 10, 1379-1390.
122. Weterings, E.; van Gent, D.C. The mechanism of non-homologous end-joining: a synopsis of synapsis. DNA Repair (Amst), 2004, 3, 1425-1435.
123. Chang, C.; Biedermann, K.A.; Mezzina, M.; Brown, J.M. Characterization of the DNA double strand break repair defect in scid mice. Cancer Res., 1993, 53, 1244-1248.
124. Pang, D.; Yoo, S.; Dynan, W.S.; Jung, M.; Dritschilo, A. Ku proteins join DNA fragments as shown by atomic force microscopy. Cancer Res., 1997, 57, 1412-1415.
125. Dynan, W.S.; Yoo, S. Interaction of Ku protein and DNA-dependent protein kinase catalytic subunit with nucleic acids. Nucleic Acids Res., 1998, 26, 1551-1559.
126. Nick McElhinny, S.A.; Havener, J.M.; Garcia-Diaz, M.; Juarez, R.; Bebenek, K.; Kee, B.L.; Blanco, L.; Kunkel, T.A.; Ramsden, D.A. A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining. Mol. Cell, 2005, 19, 357-366.
127. Mahajan, K.N.; Gangi-Peterson, L.; Sorscher, D.H.; Wang, J.; Gathy, K.N.; Mahajan, N.P.; Reeves, W.H.; Mitchell, B.S. Association of terminal deoxynucleotidyl transferase with Ku. Proc. Natl. Acad. Sci. USA, 1999, 96, 13926-13931.
128. Lee, J.W.; Blanco, L.; Zhou, T.; Garcia-Diaz, M.; Bebenek, K.; Kunkel, T.A.; Wang, Z.; Povirk, L.F. Implication of DNA polymerase lambda in alignment-based gap filling for nonhomologous DNA end joining in human nuclear extracts. J. Biol. Chem., 2004, 279, 805-811.
129. Ma, Y.; Pannicke, U.; Schwarz, K.; Lieber, M.R. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell, 2002, 108, 781-794.
130. Grawunder, U.; Wilm, M.; Wu, X.; Kulesza, P.; Wilson, T.E.; Mann, M.; Lieber, M.R. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature, 1997, 388, 492-495.
131. Bryans, M.; Valenzano, M.C.; Stamato, T.D. Absence of DNA ligase IV protein in XR-1 cells: evidence for stabilization by XRCC4. Mutat. Res., 1999, 433, 53-58.
132. Matsumoto, Y.; Suzuki, N.; Namba, N.; Umeda, N.; Ma, X.J.; Morita, A.; Tomita, M.; Enomoto, A.; Serizawa, S.; Hirano, K.; Sakaia, K.; Yasuda, H.; Hosoi, Y. Cleavage and phosphorylation of XRCC4 protein induced by X-irradiation. FEBS Lett., 2000, 478, 67-71.
133. Foster, R.E.; Nnakwe, C.; Woo, L.; Frank, K.M. Monoubiquitination of the nonhomologous end joining protein XRCC4. Biochem. Biophys. Res. Commun., 2006, 341, 175-183.
134. Yurchenko, V.; Xue, Z.; Sadofsky, M.J. SUMO modification of human XRCC4 regulates its localization and function in DNA double-strand break repair. Mol. Cell Biol., 2006, 26, 1786-1794.
135. Andres, S.N.; Modesti, M.; Tsai, C.J.; Chu, G.; Junop, M.S. Crystal structure of human XLF: a twist in nonhomologous DNA end-joining. Mol. Cell, 2007, 28, 1093-1101.
136. Hentges, P.; Ahnesorg, P.; Pitcher, R.S.; Bruce, C.K.; Kysela, B.; Green, A.J.; Bianchi, J.; Wilson, T.E.; Jackson, S.P.; Doherty, A.J. Evolutionary and functional conservation of the DNA non-homologous end-joining protein, XLF/Cernunnos. J. Biol. Chem., 2006, 281, 37517-37526.
137. Yano, K.; Morotomi-Yano, K.; Wang, S.Y.; Uematsu, N.; Lee, K.J.; Asaithamby, A.; Weterings, E.; Chen, D.J. Ku recruits XLF to DNA double-strand breaks. EMBO Rep., 2008, 9, 91-96.
138. Postow, L.; Ghenoiu, C.; Woo, E.M.; Krutchinsky, A.N.; Chait, B.T.; Funabiki, H. Ku80 removal from DNA through double strand break-induced ubiquitylation. J. Cell Biol., 2008, 182, 467-479.
139. Corneo, B.; Wendland, R.L.; Deriano, L.; Cui, X.; Klein, I.A.; Wong, S.Y.; Arnal, S.; Holub, A.J.; Weller, G.R.; Pancake, B.A.; Shah, S.; Brandt, V.L.; Meek, K.; Roth, D.B. Rag mutations reveal robust alternative end joining. Nature, 2007, 449, 483-486.
140. Xie, A.; Kwok, A.; Scully, R. Role of mammalian Mre11 in classical and alternative nonhomologous end joining. Nat. Struct. Mol. Biol., 2009, 16, 814-818.
141. Sugiyama, T.; Zaitseva, E.M.; Kowalczykowski, S.C. A single-stranded DNA-binding protein is needed for efficient presynaptic complex formation by the Saccharomyces cerevisiae Rad51 protein. J. Biol. Chem., 1997, 272, 7940-7945.
142. Wold, M.S. Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem., 1997, 66, 61-92.
143. Sung, P. Yeast Rad55 and Rad57 proteins form a heterodimer that functions with replication protein A to promote DNA strand exchange by Rad51 recombinase. Genes Dev., 1997, 11, 1111-1121.
144. Sung, P.; Robberson, D.L. DNA strand exchange mediated by a RAD51-ssDNA nucleoprotein filament with polarity opposite to that of RecA. Cell, 1995, 82, 453-461.
145. Sung, P. Catalysis of ATP-dependent homologous DNA pairing and strand exchange by yeast RAD51 protein. Science, 1994, 265, 1241-1243.
146. Shinohara, A.; Ogawa, H.; Ogawa, T. Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell, 1992, 69, 457-470.
147. Thompson, L.H.; Schild, D. Homologous recombinational repair ofHomologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat. Res., 2001, 477, 131-153.
148. Wong, A.K.; Pero, R.; Ormonde, P.A.; Tavtigian, S.V.; Bartel, P.L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem., 1997, 272, 31941-31944.
149. Galkin, V.E.; Esashi, F.; Yu, X.; Yang, S.; West, S.C.; Egelman, E.H. BRCA2 BRC motifs bind RAD51-DNA filaments. Proc. Natl. Acad. Sci. USA, 2005, 102, 8537-8542.
150. San Filippo, J.; Chi, P.; Sehorn, M.G.; Etchin, J.; Krejci, L.; Sung, P. Recombination mediator and Rad51 targeting activities of a human BRCA2 polypeptide. J. Biol. Chem., 2006, 281, 11649-11657.
151. Wolner, B.; Van Komen, S.; Sung, P.; Peterson, C.L. Recruitmentof the recombinational repair machinery to a DNA double-strand break in yeast. Mol. Cell, 2003, 12, 221-232.
152. Rossi, M.J.; Mazin, A.V. Rad51 protein stimulates the branch migration activity of Rad54 protein. J. Biol. Chem., 2008, 283, 24698-24706.
153. Maloisel, L.; Fabre, F.; Gangloff, S. DNA polymerase delta is preferentially recruited during homologous recombination to promote heteroduplex DNA extension. Mol. Cell Biol., 2008, 28, 1373-1382.
154. Liu, Y.; Masson, J.Y.; Shah, R.; O'Regan, P.; West, S.C. RAD51C is required for Holliday junction processing in mammalian cells. Science, 2004, 303, 243-246.
155. Liu, N.; Lamerdin, J.E.; Tebbs, R.S.; Schild, D.; Tucker, J.D.; Shen, M.R.; Brookman, K.W.; Siciliano, M.J.; Walter, C.A.; Fan, W.; Narayana, L.S.; Zhou, Z.Q.; Adamson, A.W.; Sorensen, K.J.; Chen, D.J.; Jones, N.J.; Thompson, L.H. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol. Cell, 1998, 1, 783-793.
156. Liu, Y.; Tarsounas, M.; O'Regan, P.; West, S.C. Role of RAD51C and XRCC3 in genetic recombination and DNA repair. J. Biol. Chem., 2007, 282, 1973-1979.
157. Lukas, J.; Lukas, C.; Bartek, J. Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair (Amst), 2004, 3, 997-1007.
158. Ahn, J.Y.; Schwarz, J.K.; Piwnica-Worms, H.; Canman, C.E. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res., 2000, 60, 5934-5936.
159. Matsuoka, S.; Huang, M.; Elledge, S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science, 1998, 282, 1893-1897.
160. Chehab, N.H.; Malikzay, A.; Appel, M.; Halazonetis, T.D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev., 2000, 14, 278-288.
161. Schwarz, J.K.; Lovly, C.M.; Piwnica-Worms, H. Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation. Mol. Cancer Res., 2003, 1, 598-609.
162. Falck, J.; Mailand, N.; Syljuasen, R.G.; Bartek, J.; Lukas, J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature, 2001, 410, 842-847.
163. Mailand, N.; Falck, J.; Lukas, C.; Syljuasen, R.G.; Welcker, M.; Bartek, J.; Lukas, J. Rapid destruction of human Cdc25A in response to DNA damage. Science, 2000, 288, 1425-1429.
164. Haupt, Y.; Maya, R.; Kazaz, A.; Oren, M. Mdm2 promotes the rapid degradation of p53. Nature, 1997, 387, 296-299.
165. Knights, C.D.; Catania, J.; Di Giovanni, S.; Muratoglu, S.; Perez, R.; Swartzbeck, A.; Quong, A.A.; Zhang, X.; Beerman, T.; Pestell, R.G.; Avantaggiati, M.L. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J. Cell Biol., 2006, 173, 533-544.
166. Roy, S.; Packman, K.; Jeffrey, R.; Tenniswood, M. Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells. Cell Death Differ., 2005, 12, 482-491.
167. Unger, T.; Sionov, R.V.; Moallem, E.; Yee, C.L.; Howley, P.M.; Oren, M.; Haupt, Y. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene, 1999, 18, 3205-3212.
168. Lambert, P.F.; Kashanchi, F.; Radonovich, M.F.; Shiekhattar, R.; Brady, J.N. Phosphorylation of p53 serine 15 increases interaction with CBP. J. Biol. Chem., 1998, 273, 33048-33053.
169. Miyashita, T.; Reed, J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 1995, 80, 293-299.
170. Nakano, K.; Vousden, K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell, 2001, 7, 683-694.
171. el Deiry, W.S.; Tokino, T.; Velculescu, V.E.; Levy, D.B.; Parsons, R.; Trent, J.M.; Lin, D.; Mercer, W.E.; Kinzler, K.W.; Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 1993, 75, 817-825.
172. Riley, T.; Sontag, E.; Chen, P.; Levine, A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol., 2008, 9, 402-412.
173. Sherr, C.J.; Roberts, J.M. Inhibitors of mammalian G1 cyclindependent kinases. Genes Dev., 1995, 9, 1149-1163.
174. Arellano, M.; Moreno, S. Regulation of CDK/cyclin complexes during the cell cycle. Int. J. Biochem. Cell Biol., 1997, 29, 559-573.
175. Hiebert, S.W.; Chellappan, S.P.; Horowitz, J.M.; Nevins, J.R. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev., 1992, 6, 177-185.
176. Chellappan, S.P.; Hiebert, S.; Mudryj, M.; Horowitz, J.M.; Nevins, J.R. The E2F transcription factor is a cellular target for the RB protein. Cell, 1991, 65, 1053-1061.
177. Hinds, P.W.; Mittnacht, S.; Dulic, V.; Arnold, A.; Reed, S.I.; Weinberg, R.A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 1992, 70, 993-1006.
178. Kerr, J.F.; Wyllie, A.H.; Currie, A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 1972, 26, 239-257.
179. Hengartner, M.O. The biochemistry of apoptosis. Nature, 2000, 407, 770-776.
180. Green, D.R.; Kroemer, G. The pathophysiology of mitochondrial cell death. Science, 2004, 305, 626-629.
181. Oda, E.; Ohki, R.; Murasawa, H.; Nemoto, J.; Shibue, T.; Yamashita, T.; Tokino, T.; Taniguchi, T.; Tanaka, N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science, 2000, 288, 1053-1058.
182. Wolff, S.; Erster, S.; Palacios, G.; Moll, U.M. p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res., 2008, 18, 733-744.
183. Nemajerova, A.; Erster, S.; Moll, U.M. The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria. Cell Death Differ., 2005, 12, 197-200.
184. Marchenko, N.D.; Wolff, S.; Erster, S.; Becker, K.; Moll, U.M. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J., 2007, 26, 923-934.